Quality key factors
Factor
Value
Sales Growth (5y)
12.64%
EBIT Growth (5y)
14.60%
EBIT to Interest (avg)
15.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0
Tax Ratio
1.81%
Dividend Payout Ratio
13.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.67%
ROE (avg)
6.87%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.80
EV to EBIT
18.86
EV to EBITDA
12.73
EV to Capital Employed
1.64
EV to Sales
2.95
PEG Ratio
NA
Dividend Yield
0.81%
ROCE (Latest)
8.70%
ROE (Latest)
9.28%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Antibiotice SA
Profit After Tax (PAT) - Half-Yearly
At RON 15.35 MM has Grown at 44.74 %
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (RON MM)
Debtors Turnover Ratio- Half Yearly
Highest at 2.50 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow - Annually
Highest at RON 105.56 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (RON MM)
Here's what is not working for Antibiotice SA
Cash and Cash Equivalents - Half Yearly
Lowest at RON 1.73 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents (RON MM)






